Rewarding Our Team as BioRender Hits $900M Valuation
As a profitable company, BioRender was able to offer liquidity to over 100 employees from their vested equity. This milestone reflects a core belief: the people who built BioRender deserve to benefit from the impact they’ve created. One of the hardest parts of building a company is the time it takes for the people doing the work to see the value they’ve created. At BioRender, we believe the scientists, designers, engineers, and operators who build our platform should be able to share in that value - on a timeline that works for them. Today, we’re announcing a new investment from Dimension Capital valuing BioRender at $900 million. As part of this transaction, we offered more than 100 employees the opportunity to realize liquidity from their vested equity. This milestone reflects something core to our values: BioRender exists because of the people who built it, and we believe they deserve to benefit from the impact they’ve made. We’re also incredibly excited to partner with the team at
Rewarding Our Team as BioRender Hits $900M Valuation Events Icon Library Learning Hub Pricing Sign in Contact Sales Sign Up Free All Posts Rewarding Our Team as BioRender Hits $900M Valuation This is some text inside of a div block. Business Rewarding Our Team as BioRender Hits $900M Valuation Start making professional scientific figures today! Sign Up Free Not a BioRender user? Sign up for a free account now. (No credit card required) Download the report First Name Last Name Email Address Current Role Company Name or Institution Are you interested in bringing BioRender premium to your departm
Explore this link on the map →related reading
- There aren't enough smart people in biology doing something boringowlposting.com
- How Life Sciences Actually Work: Findings of a Year-Long Investigation - Alexey Guzeyguzey.com
- jsomers.net | I should have loved biologyjsomers.net
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- The Hard Thing #5: The Myth of Platform Biotechthehardthing.substack.com
- Why there are no cracked biotechnologists?partialagonism.substack.com
- He Left MIT At 22 To Solve A Problem Investors Didn’t Get. Now His Company Is Worth $6 Billionforbes.com
- How Software in the Life Sciences Actually Works (And Doesn’t Work) - New Sciencenewscience.org
- Tech vs Biotech - Celine Haliouacelinehh.com
- On AI Infrastructure in Biology - by Elliot Hershbergcenturyofbio.com
- Paving the way for agents in biology \ Anthropicanthropic.com
- Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio